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cardiomyopathy, CAD and valvular heart disease. Strictly us-
ing the criteria for the definition of IVNC, IVNC is a rare un-
derlying cardiomyopathy for both, heart failure (2.7%) and 
heart transplantation (2%) in our center. 
 Copyright © 2008 S. Karger AG, Basel 
 Introduction 
 Heart failure, a common cause of hospitalization and 
death, is a worldwide growing public health problem due 
to aging of the population, improved therapy and pro-
longed survival after cardiac events  [1] . The lifetime like-
lihood of developing heart failure is approximately 20% 
at all ages above 40 years  [2, 3] . The most common etiol-
ogy of heart failure remains coronary artery disease 
(CAD); other frequent causes include hypertension, val-
vular heart disease and diabetes  [1, 4–7] . Isolated left ven-
tricular noncompaction (IVNC) seems to be a rare cause 
of heart failure. IVNC has only become widely known in 
the last 10 years  [8–10] . According to the new American 
Heart Association classification of the cardiomyopathies, 
IVNC is classified as a primary, genetic cardiomyopathy 
 [11] ; in the position statement of the European Society of 
Cardiology it is not yet classified as a distinct cardiomy-
opathy  [12] . In symptomatic patients with IVNC, heart 
 Key Words 
 Left ventricular noncompaction   Heart failure   
Heart transplantation 
 Abstract 
 Objectives: To determine the prevalence of isolated left ven-
tricular noncompaction (IVNC) as a cause of heart failure and 
heart transplantation.  Methods: There were 960 patients 
seen in the heart failure clinic from 1987 to 2005, with a com-
plete evaluation including echocardiography at our center 
(study population, 82% men, mean age 52 years). The follow-
ing data were collected: type of heart disease, age at echo-
cardiography and at heart transplantation, and frequency of 
heart transplantation. Echocardiographic diagnosis of IVNC 
was based on our published criteria.  Results: The etiologies 
of heart failure were coronary artery disease (CAD; 37%), id-
iopathic dilated cardiomyopathy (33%), valvular heart dis-
ease (11%), congenital heart disease (5%), IVNC (3%), hyper-
tensive heart disease (3%), hypertrophic cardiomyopathy 
(2%), myocarditis (1%), and  ! 1% other diagnoses. Heart 
transplantation was performed in 253 patients (26%) due to 
idiopathic dilated cardiomyopathy (42%), CAD (39%), valvu-
lar heart disease (5%), congenital heart disease (5%), IVNC 
(2%), or other etiologies ( ^  1% each).  Conclusions: The most 
common causes for heart failure remain idiopathic dilated 
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failure is common occurring in 34% and heart transplan-
tation has been reported to be necessary in up to 14%  [13] . 
However, the true prevalence of IVNC as a cause of heart 
failure and heart transplantation is unknown. In a recent 
study by Kohli et al.  [14] , involving 199 patients from a 
heart failure clinic, 23.6% fulfilled one or more published 
echocardiographic criteria for IVNC.
 The goal of the present study was to evaluate the prev-
alence of IVNC as a cause of heart failure and heart trans-
plantation in our center where since 1986 all patients have 
been routinely screened for IVNC by echocardiography.
 Methods 
 We performed a retrospective analysis of our heart failure 
clinic database which was started in 1987. There were 960 patients 
in this database from January 1987 to December 2005, who were 
evaluated with a complete history, physical exam and echocar-
diography at our hospital. This constituted the study population. 
Retrospectively, all charts and echocardiography reports were re-
viewed.
 Echocardiography 
 Complete two-dimensional and Doppler echocardiography 
was performed in all patients according to the published guide-
lines  [15] .
 Since 1985, our group has been familiar with the diagnosis of 
IVNC and has been especially interested in its occurrence screen-
ing all patients  [8] . The echocardiographic criteria for diagnosis 
of IVNC which were previously described by Jenni et al. [10, 16] 
were used. They include absence of coexisting cardiac abnormal-
ities; segmental thickening of the left ventricular myocardial wall 
consisting of two layers: a thin compacted epicardial layer and a 
thickened endocardial layer with prominent trabeculations, and 
deep recesses with color Doppler evidence of blood flow from
the left ventricular cavity to the deep intertrabecular recesses.
A thickness ratio of noncompacted to compacted myocardium 
 6 2: 1 at end systole is considered to be diagnostic of IVNC. Pre-
dominant localization of the pathology is in the apical midlateral 
and midinferior regions of the left ventricle and most of the non-
compacted segments are hypokinetic.
 Statistical Analysis 
 Results are presented as mean values  8 standard deviation or 
frequency expressed as a percentage for dichotomous or qualita-
tive variables. Nonparametric tests including Mann-Whitney U 
test as well as Fisher’s exact test were used where appropriate. p  ! 
0.05 was considered statistically significant.
 Results 
 There were 788 men (82%). Average age at echocar-
diography was 52  8 14 years overall (range 6–88), 51  8 
16 years in women (range 11–84) and 52  8 13 years in 
men (range 6–88; p = 0.24). The main etiologies of heart 
failure are shown in  table 1 . The diagnostic criteria for 
IVNC were fulfilled in 26 patients (3%). 
 Heart transplantation was performed in 253 patients 
(26%): in 214 men (85%) and 39 women (15%). Average 
age at transplantation was 48  8 12 years (range 6–66): 45 
Table 1. Etiologies of heart failure
All patients Men
(n = 788)
Women
(n = 172)
p value
CAD 359 (37) 326 (41) 33 (19) <0.0001
Dilated cardiomyopathy 319 (33) 266 (34) 53 (31) 0.48
Valvular heart disease 104 (11) 77 (10) 27 (16) 0.03
Congenital heart disease 49 (5) 31 (4) 18 (11) 0.002
IVNC 26 (3) 19 (2) 7 (4) 0.30
Hypertensive heart disease 26 (3) 17 (2) 9 (5) 0.04
Hypertrophic cardiomyopathy 15 (2) 13 (1.6) 2 (1) 1.0
Myocarditis 11 (1) 8 (1) 3 (1.5) 0.43
Amyloid heart disease 9 (0.9) 5 (0.6) 4 (2.0) 0.06
Arrhythmogenic right ventricular cardiomyopathy 9 (0.9) 7 (0.9) 2 (1) 0.67
Idiopathic restrictive cardiomyopathy 8 (0.8) 3 (0.4) 5 (3) 0.006
Neuromuscular disease 7 (0.7) 6 (0.8) 1 (0.5) 1.0
Unknown 7 (0.7) 5 (0.6) 2 (1) 0.62
Other 11 (1) 5 (0.6) 6 (4) 0.006
Figures in parentheses are percentage.
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 8 14 years in women (range 12–61) and 48  8 12 years in 
men (range 6–66; p = 0.22). The main etiologies of heart 
transplantation are shown in  table 2 . As in the heart fail-
ure group, the most common valvular lesions in the heart 
transplant patients were mitral regurgitation (1.6%) and 
aortic stenosis (0.8%). IVNC as a cause of heart trans-
plantation was present in 5 patients (2%) with mean age 
at heart transplantation of 47  8 14 years (range 26–61). 
No other patients with IVNC were considered for heart 
transplantation but found ineligible or died on the wait-
ing list. 
 The main etiology of heart failure by age at heart 
transplantation was also analyzed as shown in  table 3 . 
Patients were divided into three groups: 18 years of age or 
younger, 19–50 years of age and more than 50 years of 
age. The prevalence of CAD as a cause of heart transplan-
tation increased with age. On the other hand, congenital 
heart disease, idiopathic restrictive cardiomyopathy and 
myocarditis were the most common causes of heart trans-
plantation in the group of patients of 18 years of age or 
younger.
 The main etiologies of heart failure analyzed by gender 
at heart transplantation are shown in  table 4 . We found 
no statistically significant difference between men and 
women with respect to all causes of heart transplantation 
except for CAD which was a significantly more common 
cause of heart transplantation in men (p = 0.01).
 To analyze the impact of better image quality and in-
creased awareness of IVNC, we were able to analyze the 
overall prevalence of the diagnosis of IVNC in the echo-
cardiography laboratory (thus the total number is higher 
than 26 patients) between 1990 and 2005 in relative and 
absolute numbers as shown in  figure 1 . The years before 
1990 were not available for detailed analysis. In 2004 and 
2005, there was a significant increase in the diagnosis 
which cannot only be attributed to examination of rela-
tives of patients with known IVNC (p = 0.02, Mann-
Whitney test).
 Discussion 
 Our data show that IVNC strictly using the definitions 
by Jenni et al.  [10] is a rare cause of heart failure and heart 
transplantation in our center compared to CAD, dilated 
cardiomyopathy or valvular heart disease. The preva-
lence of IVNC in this patient group seems comparable to 
that of hypertrophic cardiomyopathy.
Table 2. Etiologies of heart transplantation in 253 patients
Number of patients
CAD 98 (39)
Dilated cardiomyopathy 107 (42)
Valvular heart disease 13 (5)
Congenital heart disease 13 (5)
IVNC 5 (2)
Hypertensive heart disease 2 (0.8)
Hypertrophic cardiomyopathy 0
Myocarditis 3 (1)
Amyloid heart disease 3 (1)
Arrhythmogenic right ventricular 
cardiomyopathy 2 (0.8)
Idiopathic restrictive cardiomyopathy 3 (1)
Neuromuscular disease 2 (0.8)
Cardiomyopathy of unknown origin 2 (0.8)
Figures in parentheses are percentage. 
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 Fig. 1. Prevalence of diagnosis of IVNC in 
the echocardiography laboratory from 
1990 to 2005. The number of patients with 
IVNC seen in the echocardiography labo-
ratory in the individual years is shown. 
The total number of patients per year was 
4,051 patients in 1990 increasing to 4,871 
patients in 2005. 
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 Main Causes of Heart Failure and Heart 
Transplantation 
 The underlying cardiac diagnoses in an Italian regis-
try of over 6,200 outpatients with heart failure included 
CAD in 40%, dilated cardiomyopathy in 32%, primary 
valvular heart disease in 32% and hypertensive heart dis-
ease in 11%; other diagnoses were more rare  [17] . Among 
960 patients in our study group, the frequency of CAD 
and dilated cardiomyopathy was almost the same as in 
the Italian registry (37 and 33%, respectively), whereas 
primary valvular heart disease and hypertensive heart 
disease with 11 and 3% were less common. IVNC as a 
cause of heart failure was as common as hypertrophic 
cardiomyopathy present in 2.7% of patients.
 The 23rd Official Adult Heart Transplantation Report 
2006 of the International Society for Heart and Lung 
Transplantation (ISHLT)  [18] presented information on 
73,000 transplanted patients. During the last 5 years, 
CAD was the indication for transplantation in 42% of 
cases, and noncoronary cardiomyopathy in 46%, whereas 
valvular and congenital heart disease was present in only 
3 and 2% of transplanted patients, respectively. In our 
cohort, CAD was the underlying cardiomyopathy in 39% 
of patients, dilated cardiomyopathy in 42%, and valvular 
Table 3. Etiologies of heart failure by age at heart transplantation
Age ≤18 years
(n = 12)
Age 19–50 years
(n = 112)
Age >50 years
(n = 129)
p valuea
CAD 0 35 (31) 63 (48) 0.0001
Dilated cardiomyopathy 5 (42) 51 (45) 51 (40) 0.66
Valvular heart disease 0 7 (6) 6 (5) 0.88
Congenital heart disease 4 (33) 8 (7) 1 (0.8) 0.0001
IVNC 0 2 (2) 3 (2) 1.0
Hypertensive heart disease 0 0 (0) 2 (1.6) 0.55
Myocarditis 2 (17) 1 (0.9) 0 0.003
Amyloid heart disease 0 2 (2) 1 (0.8) 0.65
Arrhythmogenic right ventricular cardiomyopathy 0 2 (2) 0 0.29
Idiopathic restrictive cardiomyopathy 1 (8) 1 (0.9) 1 (0.8) 0.14
Neuromuscular disease 0 2 (2) 0 0.29
Cardiomyopathy of unknown origin 0 1 (0.9) 1 (0.8) 1.0
Figures in parentheses are percentage. a p value by Fisher’s exact test.
Table 4. Etiologies of heart failure by gender at heart transplantation
Male gender
(n = 214)
Female gender
(n = 39)
p value
CAD 90 (42) 8 (21) 0.01
Dilated cardiomyopathy 88 (41) 19 (49) 0.38
Valvular heart disease 13 (6) 0 (0) 0.23
Congenital heart disease 9 (4) 4 (10) 0.12
IVNC 4 (2) 1 (2.5) 0.57
Hypertensive heart disease 1 (0.5) 1 (2.5) 0.29
Myocarditis 2 (1) 1 (2.5) 0.40
Amyloid heart disease 1 (0.5) 2 (5) 0.06
Arrhythmogenic right ventricular cardiomyopathy 1 (0.5) 1 (2.5) 0.29
Idiopathic restrictive cardiomyopathy 1 (0.5) 2 (5) 0.06
Neuromuscular disease 2 (1) 0 1.0
Cardiomyopathy of unknown origin 2 (1) 0 1.0
Figures in parentheses are percentage.
D
ow
nl
oa
de
d 
by
: 
Un
ive
rs
itä
t Z
ür
ich
,  
Ze
nt
ra
lb
ib
lio
th
ek
 Z
ür
ich
   
   
   
 
13
0.
60
.4
7.
22
 - 
7/
6/
20
16
 5
:3
5:
56
 P
M
 Kovacevic-Preradovic /Jenni /Oechslin /
Noll /Seifert /Attenhofer Jost 
Cardiology 2009;112:158–164162
and congenital heart disease in 5% of patients each. IVNC 
was the next most common cause of heart transplanta-
tion with 2%. Thus, our cohort was comparable to the 
ISHLT data – apart from the information on IVNC which 
was missing in the ISHLT 2006 report. In a recent study 
of primary cardiomyopathy in Australian children, 
IVNC was the third most common cardiomyopathy after 
dilated cardiomyopathy and hypertrophic cardiomyopa-
thy  [19] . In another single center series, IVNC was re-
sponsible for 9.5% of cardiomyopathies in children  [20] . 
 Definition of IVNC and Cardiomyopathies 
 The diagnosis of IVNC has become widely known af-
ter the establishment of clear-cut diagnostic criteria for 
echocardiography  [9] , and, therefore, patients are nowa-
days routinely screened for this diagnosis. IVNC was re-
cently classified as a primary, genetic cardiomyopathy ac-
cording to the American Heart Association  [11] ; in the 
position statement of the European Society of Cardiolo-
gy, IVNC is not classified as a distinct cardiomyopathy 
 [12] .
 The most widely used diagnostic criteria are the ones 
proposed by our group  [10] . The first diagnostic criteria 
for IVNC were published by Chin et al.  [9] , defining 
IVNC criteria at end diastole, requiring a ratio of  ! 0.5 
which is very similar to the approach of Jenni et al. Stoll-
berger et al.  [21]  proposed to use the criterion of more 
than three trabeculations protruding from the left ven-
tricular wall, apically to the papillary muscles, visible in 
a single image plane in combination with intertrabecular 
spaces perfused from the left ventricular cavity.
 Prevalence of IVNC in Patients 
 The increasing prevalence of IVNC also in the echo-
cardiography laboratory shows that, even in our hands, 
IVNC might have been undetected in some patients in 
the past due to previous technical inadequacy of the echo-
cardiographic machines. The results of our center are 
unique as all patients with heart failure have been screened 
for this diagnosis since 1986. 
 A recent study by Kohli et al.  [14]  suggested that at least 
one set of IVNC criteria may be fulfilled in up to 23.6% 
of 199 patients in their heart failure clinic with an in-
creased prevalence in black patients. These authors used 
all 3 published criteria for IVNC: by Chin et al.  [9] , by 
Jenni et al.  [10] , and by Stollberger et al.  [21] . The defini-
tions by Jenni et al. were fulfilled in 30 patients, the cri-
teria of Chin et al. in 37 patients and the criteria proposed 
by Stollberger et al. in 25 patients. The findings of this 
study do not suggest that IVNC is indeed such a common 
cause of heart failure, but that the proposed criteria have 
to be defined more strictly or to be applied more care-
fully. For the definitions by Jenni et al., wall thickening 
of the affected wall is a very important criterion and is 
neglected by many who try to apply the criteria. In many 
publications, wall thickening is not mentioned as a crite-
rion. There is no doubt that the entity of IVNC does exist; 
however, as some persistence of the trabecular layer seems 
to be quite common, the cutoff for the extent where it is 
clinically significant has to be defined carefully.
 In one study cohort with 45 patients, 8 of 32 screened 
relatives had a range of echocardiographic abnormalities 
including IVNC or left ventricular enlargement without 
IVNC, features resembling dilated cardiomyopathy with 
recesses  [22] . This is similar to hypertrophic cardiomy-
opathy where definite carriers do not necessarily have all 
features or variable features due to variable penetrance of 
the phenotype, or where some definite cardiac   -myosin 
heavy chain defect carriers may show features resembling 
noncompaction  [23] . This does not prove that IVNC may 
not present itself as a distinct cardiomyopathy but that a 
spectrum of abnormal maturation of the myocardium 
may be quite common with only the most severe forms 
producing a pathological entity  [24] .
 Heart Transplantation and IVNC 
 Whereas the prognosis of symptomatic IVNC is poor, 
so far only rare cases of heart transplantation in IVNC 
have been described  [13, 25, 26] . Pathologic examination 
of the explanted hearts nicely demonstrated the underly-
ing pathology. Interestingly enough, the diagnosis was 
not commonly made at pathology in the past, but most 
pathologists became aware of the disease when it had 
been described at catheterization and by echocardiogra-
phy. Therefore, the true prevalence of IVNC as a cause for 
heart transplantation if examining only the explanted 
hearts or in large autopsy series may be underestimated. 
Besides, as shown in the beautiful paper by Burke et al. 
 [27] , IVNC can be variable even at autopsy presenting as 
anastomosing broad trabeculae, coarse trabeculae re-
sembling multiple papillary muscles or interlacing small-
er muscle bundles resembling a sponge. This makes the 
diagnosis even more difficult. 
 Limitations 
 The retrospective study design and the selection bias 
of a tertiary care center are the major limitations. The 
prevalence of several etiologies of heart failure is likely to 
be underestimated in the heart failure clinic in our hos-
pital as patients with HIV cardiomyopathy, chemothera-
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py-induced cardiomyopathy, heart failure due to connec-
tive tissue disease or cardiomyopathy due to end-stage 
systemic disease (amyloid heart disease) might not be re-
ferred to the same degree as heart failure with other di-
agnoses.
 The prevalence of the different etiologies of heart fail-
ure does not reflect the whole age spectrum as elderly 
patients might not be referred to the heart failure clinic 
as frequently as younger people.
 Typically, patients seen in the heart failure clinic are 
symptomatic. We cannot determine the prevalence of 
IVNC in patients with asymptomatic left ventricular dys-
function. However, we suspect that the prevalence may 
even be higher than we assume, as asymptomatic patients 
with IVNC are increasingly detected due to the increased 
awareness of this cardiomyopathy  [13] .
 Diastolic heart failure is increasingly recognized in 
the population defined as signs and symptoms of heart 
failure and preserved systolic function  [28] . Isolated dia-
stolic dysfunction is present in more than 40% of patients 
with heart failure  [29] . However, diastolic heart failure as 
a specific diagnosis has not been coded as such in our da-
tabase and is included in the other diagnosis groups.
 Conclusion 
 The most common causes for heart failure and heart 
transplantation remain dilated cardiomyopathy, CAD 
and valvular heart disease. Among patients followed in 
our heart failure clinic, IVNC is a rare underlying cardio-
myopathy for both, heart failure (2.7%) and heart trans-
plantation (2%). However, its prevalence is comparable to 
hypertrophic cardiomyopathy if the diagnostic criteria 
are known and used correctly.
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